Cordant Health Solutions® partners with clinician practices to provide a stigma-free pharmacy solution that specializes in safely and securely dispensing medications for medication-assisted treatment (MAT) for opioid and substance use disorders.
95% of patients that participated in a 2020 survey, said they are more likely to stick with their addiction treatment plan since using Cordant’s pharmacy program.*
Cordant’s on-site buprenorphine program eliminates many of the barriers to treatment that patients face including poor treatment at retail pharmacies, challenges with transportation and limited or no availability of medication when needed, and can help improve patient adherence to their treatment plan.
*Based on 540 patient responses from an ongoing patient experience survey May-June 2020
Patients in Cordant’s buprenorphine program showed significantly higher retention rates, especially in the early part of treatment¹
Patients are more likely to keep their appointments when they receive their medications from Cordant at the time of their clinic visit²
Patients in Cordant’s program had fewer drug-related ER visits²
Patients in Cordant’s program experienced fewer relapse events³
1Analysis of 154 patients 90 days or less in treatment prior to on-site program; Nov. 2016–Oct. 2017 and 154 patients 90 days or less in treatment participating in on-site program; Nov. 2017–Oct. 2018
2Analysis of 236 patients in treatment prior to on-site program; Nov. 2016–Oct. 2017 and 300 patients in treatment participating in on-site program; Nov. 2017–Oct. 2018
Please complete this form to request more information about our in-office buprenorphine solution.